Effects of hyperandrogenemia and increased adiposity on reproductive and metabolic parameters in young adult female monkeys.

Many patients with hyperandrogenemia are overweight or obese, which exacerbates morbidities associated with polycystic ovary syndrome (PCOS). To examine the ability of testosterone (T) to generate PCOS-like symptoms, monkeys received T or cholesterol (control) implants (n = 6/group) beginning prepubertally. As previously reported, T-treated animals had increased neuroendocrine drive to the reproductive axis [increased luteinizing hormone (LH) pulse frequency] at 5 yr, without remarkable changes in ovarian or metabolic features. To examine the combined effects of T and obesity, at 5.5 yr (human equivalent age: 17 yr), monkeys were placed on a high-calorie, high-fat diet typical of Western cultures [Western style diet (WSD)], which increased body fat from <2% (pre-WSD) to 15-19% (14 mo WSD). By 6 mo on WSD, LH pulse frequency in the controls increased to that of T-treated animals, whereas LH pulse amplitude decreased in both groups and remained low. The numbers of antral follicles present during the early follicular phase increased in both groups on the WSD, but maximal follicular size decreased by 50%. During the late follicular phase, T-treated females had greater numbers of small antral follicles than controls. T-treated monkeys also had lower progesterone during the luteal phase of the menstrual cycle. Although fasting insulin did not vary between groups, T-treated animals had decreased insulin sensitivity after 1 yr on WSD. Thus, while WSD consumption alone led to some features characteristic of PCOS, T + WSD caused a more severe phenotype with regard to insulin insensitivity, increased numbers of antral follicles at midcycle, and decreased circulating luteal phase progesterone levels.

[1]  N. van Bruggen,et al.  Targeting oxidized LDL improves insulin sensitivity and immune cell function in obese Rhesus macaques. , 2013, Molecular metabolism.

[2]  J. Cameron,et al.  Elevated androgens during puberty in female rhesus monkeys lead to increased neuronal drive to the reproductive axis: a possible component of polycystic ovary syndrome. , 2012, Human reproduction.

[3]  S. Uludağ,et al.  The influence of obesity on ICSI outcomes in women with polycystic ovary syndrome , 2011, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[4]  L. Giudice,et al.  Progesterone resistance in PCOS endometrium: a microarray analysis in clomiphene citrate-treated and artificial menstrual cycles. , 2011, The Journal of clinical endocrinology and metabolism.

[5]  J. Bonde,et al.  A very large proportion of young Danish women have polycystic ovaries: is a revision of the Rotterdam criteria needed? , 2010, Human reproduction.

[6]  S. Caprio,et al.  Hyperandrogenemia in Obese Peripubertal Girls: Correlates and Potential Etiological Determinants , 2010, Obesity.

[7]  B. Sternfeld,et al.  The polycystic ovary post-rotterdam: a common, age-dependent finding in ovulatory women without metabolic significance. , 2010, The Journal of clinical endocrinology and metabolism.

[8]  C. Lindgren,et al.  The Genetics of Obesity , 2010, Current diabetes reports.

[9]  M. McCarthy,et al.  Patterns of ovarian morphology in polycystic ovary syndrome: a study utilising magnetic resonance imaging , 2010, European Radiology.

[10]  A. Nobre,et al.  Chronic Consumption of a High-Fat Diet during Pregnancy Causes Perturbations in the Serotonergic System and Increased Anxiety-Like Behavior in Nonhuman Primate Offspring , 2010, The Journal of Neuroscience.

[11]  K. Flegal,et al.  Prevalence and trends in obesity among US adults, 1999-2008. , 2010, JAMA.

[12]  R. Stouffer,et al.  Evaluation of antral follicle growth in the macaque ovary during the menstrual cycle and controlled ovarian stimulation by high‐resolution ultrasonography , 2009, American journal of primatology.

[13]  E. Littlejohn,et al.  Blunted sleep-related luteinizing hormone rise in healthy premenarcheal pubertal girls with elevated body mass index. , 2009, The Journal of clinical endocrinology and metabolism.

[14]  S. Morán,et al.  Obesity differentially affects serum levels of androstenedione and testosterone in polycystic ovary syndrome. , 2008, Fertility and sterility.

[15]  L. Ferrucci,et al.  High basal metabolic rate is a risk factor for mortality: the Baltimore Longitudinal Study of Aging. , 2008, The journals of gerontology. Series A, Biological sciences and medical sciences.

[16]  X. Bertagna,et al.  Luteinizing hormone pulsatility in patients with major ovarian hyperandrogenism , 2007, Journal of endocrinological investigation.

[17]  G. Di Fede,et al.  Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance. , 2007, The Journal of clinical endocrinology and metabolism.

[18]  Nathan J. Rockcastle,et al.  Physical activity of adult female rhesus monkeys (Macaca mulatta) across the menstrual cycle. , 2007, American journal of physiology. Endocrinology and metabolism.

[19]  Antonio Maria Morselli-Labate,et al.  Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study. , 2006, The Journal of clinical endocrinology and metabolism.

[20]  J. Cameron,et al.  Individual differences in physical activity are closely associated with changes in body weight in adult female rhesus monkeys (Macaca mulatta). , 2006, American journal of physiology. Regulatory, integrative and comparative physiology.

[21]  P. Hsu,et al.  Presence and progression of abdominal obesity are predictors of future high blood pressure and hypertension. , 2006, American journal of hypertension.

[22]  S. Witchel Puberty and polycystic ovary syndrome , 2006, Molecular and Cellular Endocrinology.

[23]  J. Marshall,et al.  The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome. , 2006, Human reproduction update.

[24]  J. Marshall,et al.  The association of obesity and hyperandrogenemia during the pubertal transition in girls: obesity as a potential factor in the genesis of postpubertal hyperandrogenism. , 2006, The Journal of clinical endocrinology and metabolism.

[25]  Janet E Hall,et al.  Inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome: investigation of hypothalamic and pituitary contributions. , 2006, The Journal of clinical endocrinology and metabolism.

[26]  J. Cameron,et al.  Evidence in female rhesus monkeys (Macaca mulatta) that nighttime caloric intake is not associated with weight gain. , 2005, Obesity research.

[27]  M. Sowers,et al.  Weight, fat mass, and central distribution of fat increase when women use     depot-medroxyprogesterone acetate for contraception , 2005, International Journal of Obesity.

[28]  G. Dallal,et al.  Energy requirements and aging. , 2005, Public health nutrition.

[29]  L. Williams,et al.  Identifying the energy gap: magnitude and determinants of 5-year weight gain in midage women. , 2005, Obesity research.

[30]  J. Marshall,et al.  Progesterone inhibition of the hypothalamic gonadotropin-releasing hormone pulse generator: evidence for varied effects in hyperandrogenemic adolescent girls. , 2005, The Journal of clinical endocrinology and metabolism.

[31]  S. Agarwal,et al.  Effects of metformin treatment on luteal phase progesterone concentration in polycystic ovary syndrome. , 2004, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[32]  K. Taylor,et al.  Androgen excess in women: experience with over 1000 consecutive patients. , 2004, The Journal of clinical endocrinology and metabolism.

[33]  J. Marshall,et al.  Obese patients with polycystic ovary syndrome: evidence that metformin does not restore sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by ovarian steroids. , 2003, The Journal of clinical endocrinology and metabolism.

[34]  M. Ferin,et al.  Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents. , 2003, The Journal of clinical endocrinology and metabolism.

[35]  S. E. Rankin,et al.  Effects of tibolone and conjugated equine estrogens with or without medroxyprogesterone acetate on body composition and fasting carbohydrate measures in surgically postmenopausal monkeys. , 2003, Metabolism: clinical and experimental.

[36]  W. Rosner,et al.  Sex Difference in the Effect of Obesity on 24-Hour Mean Serum Gonadotropin Levels , 2003, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[37]  R. Colman,et al.  Increased adiposity in female rhesus monkeys exposed to androgen excess during early gestation. , 2003, Obesity research.

[38]  V. Castracane,et al.  Polycystic ovarian syndrome and insulin resistance in white and Mexican American women: a comparison of two distinct populations. , 2002, American journal of obstetrics and gynecology.

[39]  J. Marshall,et al.  Regulation of Gonadotropin Secretion: Implications for Polycystic Ovary Syndrome , 2002, Seminars in reproductive medicine.

[40]  S. Franks Adult polycystic ovary syndrome begins in childhood. , 2002, Best practice & research. Clinical endocrinology & metabolism.

[41]  M. Ferin,et al.  Inadequate luteal function is the initial clinical cyclic defect in a 12-day stress model that includes a psychogenic component in the Rhesus monkey. , 2002, The Journal of clinical endocrinology and metabolism.

[42]  J. Cameron,et al.  Longitudinal changes in reproductive hormones and menstrual cyclicity in cynomolgus monkeys during strenuous exercise training: abrupt transition to exercise-induced amenorrhea. , 2001, Endocrinology.

[43]  S. Kirchengast,et al.  Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome. , 2001, Human reproduction.

[44]  C J Henry,et al.  Mechanisms of changes in basal metabolism during ageing , 2000, European journal of clinical nutrition.

[45]  R. Legro The Genetics of Obesity Lessons for Polycystic Ovary Syndrome , 2000, Annals of the New York Academy of Sciences.

[46]  Jane E. Robinson,et al.  In Utero Exposure of Female Lambs to Testosterone Reduces the Sensitivity of the GnRH Neuronal Network to Inhibition by Progesterone. , 1999, Endocrinology.

[47]  J. López-Fernández,et al.  Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders. , 1999, Fertility and sterility.

[48]  K. Watkin,et al.  Ovarian stromal echogenicity in women with normal and polycystic ovaries. , 1999, Human reproduction.

[49]  T. Key,et al.  Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. , 1998, The Journal of clinical endocrinology and metabolism.

[50]  C. Bondy,et al.  Androgens stimulate early stages of follicular growth in the primate ovary. , 1998, The Journal of clinical investigation.

[51]  J. Marshall,et al.  Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. , 1998, The Journal of clinical endocrinology and metabolism.

[52]  S. Yen,et al.  Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity. , 1997, The Journal of clinical endocrinology and metabolism.

[53]  D. Schoenfeld,et al.  Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. , 1997, The Journal of clinical endocrinology and metabolism.

[54]  F. Wu,et al.  Energy metabolism during male human puberty. I. Changes in energy expenditure during the onset of puberty in boys. , 1996, Annals of human biology.

[55]  J. Rood,et al.  Exogenous androgens influence body composition and regional body fat distribution in obese postmenopausal women--a clinical research center study. , 1996, The Journal of clinical endocrinology and metabolism.

[56]  J. Schenker,et al.  Endocrinology: Insulin resistant and non-resistant polycystic ovary syndrome represent two clinical and endocrinological subgroups , 1995 .

[57]  C. Berne,et al.  Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables , 1994, Clinical endocrinology.

[58]  D. Apter,et al.  Accelerated 24-hour luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovarian syndrome. , 1994, The Journal of clinical endocrinology and metabolism.

[59]  R. Lobo,et al.  Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? , 1992, American journal of obstetrics and gynecology.

[60]  R. Klesges,et al.  A longitudinal analysis of the impact of dietary intake and physical activity on weight change in adults. , 1992, The American journal of clinical nutrition.

[61]  E. Poehlman,et al.  Endurance training increases metabolic rate and norepinephrine appearance rate in older individuals. , 1991, The American journal of physiology.

[62]  J. Cameron,et al.  Suppression of pulsatile luteinizing hormone and testosterone secretion during short term food restriction in the adult male rhesus monkey (Macaca mulatta). , 1991, Endocrinology.

[63]  H. Mason,et al.  DIFFERENCES IN CLINICAL AND ENDOCRINE FEATURES BETWEEN OBESE AND NON‐OBESE SUBJECTS WITH POLYCYSTIC OVARY SYNDROME: AN ANALYSIS OF 263 CONSECUTIVE CASES , 1990, Clinical endocrinology.

[64]  R. Bergman Toward Physiological Understanding of Glucose Tolerance: Minimal-Model Approach , 1989, Diabetes.

[65]  R. Mclachlan,et al.  Luteal phase deficiency: characterization of reproductive hormones over the menstrual cycle. , 1989, The Journal of clinical endocrinology and metabolism.

[66]  K. Segal,et al.  Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome , 1989, Diabetes.

[67]  N. Faure,et al.  Assessment of ovaries by magnetic resonance imaging in patients presenting with polycystic ovarian syndrome. , 1989, Human reproduction.

[68]  J. Faure,et al.  Segmental Duct-Obstructed Pancreas Grafts Versus Pancreaticoduodenal Grafts With Enteric Diversion , 1989, Diabetes.

[69]  J. Adams,et al.  Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. , 1988, BMJ.

[70]  S. Yen,et al.  Circulating Luteinizing Hormone Pulse Frequency in Women with Polycystic Ovary Syndrome , 1987 .

[71]  J. Garrow,et al.  Effect of a 10‐week aerobic exercise programme on metabolic rate, body composition and fitness in lean sedentary females , 1987, The British journal of clinical practice.

[72]  K. Pennert,et al.  Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. , 1984, British medical journal.

[73]  J. Marshall,et al.  Pulsatile gonadotropin secretion during the human menstrual cycle: evidence for altered frequency of gonadotropin-releasing hormone secretion. , 1984, The Journal of clinical endocrinology and metabolism.

[74]  D. Bangsberg,et al.  Pulsatile secretion of luteinizing hormone during the menstrual cycle of rhesus macaques. , 1984, Endocrinology.

[75]  R. Hoffmann,et al.  Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolic aberrations in premenopausal women. , 1983, The Journal of clinical endocrinology and metabolism.

[76]  C. Rao,et al.  Plasma gonadotropin and sex steroid hormone levels during early, midfollicular, and midluteal phases of women with luteal phase defects. , 1983, Fertility and sterility.

[77]  K. Wachter,et al.  Algorithms for the study of episodic hormone secretion. , 1982, The American journal of physiology.

[78]  G. Hodgen,et al.  Luteal phase dysfunction infertility: a sequel to aberrant folliculogenesis. , 1981, Fertility and sterility.

[79]  R. Stouffer,et al.  Induction of luteal phase defects in rhesus monkeys by follicular fluid administration at the onset of the menstrual cycle. , 1980, The Journal of clinical endocrinology and metabolism.

[80]  Y. Z. Ider,et al.  Quantitative estimation of insulin sensitivity. , 1979, The American journal of physiology.

[81]  S. M. Herod,et al.  Treatment with a CRH-R1 antagonist prevents stress-induced suppression of the central neural drive to the reproductive axis in female macaques. , 2011, American journal of physiology. Endocrinology and metabolism.

[82]  J. Marshall,et al.  Maturation of luteinizing hormone (gonadotropin-releasing hormone) secretion across puberty: evidence for altered regulation in obese peripubertal girls. , 2009, The Journal of clinical endocrinology and metabolism.

[83]  M. McCarthy,et al.  Hormonal profile of women with self-reported symptoms of oligomenorrhea and/or hirsutism: Northern Finland birth cohort 1966 study. , 2003, The Journal of clinical endocrinology and metabolism.

[84]  Peter J Moate,et al.  MINMOD Millennium: a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test. , 2003, Diabetes technology & therapeutics.

[85]  J. L. San Millán,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society A Prospective Study of the Prevalence of the Polycystic Ovary Syndrome in Unselected Caucasian Women from Spain* , 1999 .

[86]  R. Pasquali,et al.  Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. , 1989, The Journal of clinical endocrinology and metabolism.

[87]  W. Crowley,et al.  Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization. , 1988, The Journal of clinical endocrinology and metabolism.

[88]  A. Dunaif,et al.  The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome. , 1988, The Journal of clinical endocrinology and metabolism.